Stock Rating Report for LLY
|
|
Stock Information
| Ticker |
LLY |
| Company Name |
Eli Lilly and Co |
| Current Price |
$39.51 |
| Previous Close |
$39.51 |
| Industry |
Drug Manufacturers - Major |
| Sector |
HEALTHCARE |
| Long Stop Loss |
Members Only |
| Short Stop Loss |
Members Only |
| Expected Move |
Members Only |
| Optionable? |
Yes
|
StockProphet Ratings
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Sector Risks
Chart
We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for LLY. However, we only show it to our subscribers.
We update our ratings and stop losses EVERY WEEK.
Don't miss out on what we recommend for Eli Lilly and Co next week. Sign up today and start making money!
Demand Fundamentals
|
Demand Technicals
Company Profile
Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance- depression and diabetic peripheral neuropathic pain- attention-deficit hyperactivity disorder in children, adolescents, and adults- bulimia nervosa and obsessive-compulsive disorders- and bipolar depression and treatment-resistant depression. The company's endocrinology products are used for diabetes- type 2 diabetes- osteoporosis in postmenopausal women- osteoporosis in postmenopausal women and men at high risk for fracture- and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma- pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers- and colorectal cancers, as well as offers cardiovascular products to treat erectile dysfunction and pulmonary arterial hypertension, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and to treat adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives- antibiotics to treat respiratory and other diseases in cattle, swine, and poultry- leanness and performance enhancers for swine and cattle- protein supplements to improve milk productivity in dairy cows- anticoccidial agents- antibiotics to control enteric infections in calves and swine- parasiticides for use on cattle and premises- products to treat canine separation anxiety- and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.
|
Latest News
| Fri, 03 Feb 2012 23:23:21 GMT | Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics | | Fri, 03 Feb 2012 19:53:58 GMT | Merck Looks Like A Name To Own In Drugs | | Fri, 03 Feb 2012 18:09:18 GMT | BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target | | Fri, 03 Feb 2012 17:56:29 GMT | Dr Reddy's fiscal 3Q profit jumps 87 percent | | Fri, 03 Feb 2012 17:47:12 GMT | This Just In: Upgrades and Downgrades | | Fri, 03 Feb 2012 15:54:19 GMT | Army Studies Workout Supplements After Deaths | | Fri, 03 Feb 2012 15:15:23 GMT | Revenues Skyrocket at Merged Alkermes | | Fri, 03 Feb 2012 14:24:14 GMT | Adocia Chief Seeks Partner Soon for Diabetic Foot-Sore Treatment | | Fri, 03 Feb 2012 13:18:06 GMT | S&P 500 Analyst Estimate Revisions for Feb. 3 | | Fri, 03 Feb 2012 12:01:15 GMT | DIARY-U.S. MEETINGS/WEEK AHEAD | | Fri, 03 Feb 2012 11:56:09 GMT | Dr Reddy's Labs Q3 net beats f'casts on U.S. sales | | Fri, 03 Feb 2012 11:56:09 GMT | Dr Reddy's Labs Q3 net beats f'casts on U.S. sales | | Fri, 03 Feb 2012 11:24:16 GMT | [$$] Dr. Reddy's Profit Soars 88% | | Fri, 03 Feb 2012 10:51:24 GMT | UPDATE 1-India's Dr Reddy's Labs Q3 net beats f'casts on U.S. sales | | Fri, 03 Feb 2012 08:04:21 GMT | Equities End a Strong Month on a Mixed Note | | Fri, 03 Feb 2012 05:01:00 GMT | Rick?s Imports Strippers as Indianapolis Readies for Super Bowl Revelers | | Fri, 03 Feb 2012 02:15:17 GMT | Ultimate Market Recap: Cereal Companies Rise, Abercrombie Plummets 11% | | Thu, 02 Feb 2012 22:29:55 GMT | Drugmakers singing same song: 2012 will be tough | | Thu, 02 Feb 2012 21:50:24 GMT | [$$] Merck Swings to Profit on Fewer Charges, Sales Growth | | Thu, 02 Feb 2012 17:53:00 GMT | Merck Reports Mixed Q4, 2012 Outlook Below Forecasts | News provided by Yahoo! Finance |
|
|
|
|